Provided by Tiger Fintech (Singapore) Pte. Ltd.

Leap Therapeutics Inc

0.3596
-0.0038-1.05%
Post-market: 0.3510-0.0086-2.39%18:20 EDT
Volume:255.91K
Turnover:90.33K
Market Cap:14.84M
PE:-0.20
High:0.3664
Open:0.3600
Low:0.3380
Close:0.3634
Loading ...

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer

PR Newswire
·
15 Apr

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer

Benzinga
·
27 Mar

Leap Therapeutics Says New Data Show Sirexatamab Improves Survival in Colorectal Cancer Trial

MT Newswires Live
·
26 Mar

BRIEF-Leap Therapeutics Reports Fourth Quarter And FY 2024 Results

Reuters
·
26 Mar

Leap Therapeutics Q4 Operating Expenses USD 16.125 Million

THOMSON REUTERS
·
26 Mar

Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire
·
26 Mar

Leap Therapeutics Reports Positive Updated Data From Sirexatamab Colorectal Cancer Study

THOMSON REUTERS
·
26 Mar

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

PR Newswire
·
26 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
14 Mar

Leap Therapeutics Shares Tumble After Downgrades from Baird, HC Wainwright

MT Newswires Live
·
30 Jan

Baird Downgrades Leap Therapeutics to Neutral From Outperform, Cuts Price Target to $1.25 From $9

MT Newswires Live
·
29 Jan

HC Wainwright Downgrades Leap Therapeutics to Neutral From Buy

MT Newswires Live
·
29 Jan

Leap Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
29 Jan

Leap Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
29 Jan

U.S. RESEARCH ROUNDUP-Apple, Coinbase Global, Nextracker

Reuters
·
29 Jan

Leap Therapeutics Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1.25 From $9

THOMSON REUTERS
·
29 Jan

Gold Gains 1%; Boeing Shares Rise Following Q4 Results

Benzinga
·
29 Jan